TAB2, an important upstream adaptor of interleukin-1 signaling pathway, is subject to SUMOylation.
SUMOylation has been considered as an important mechanism to regulate multiple cellular processes, including inflammation. TAB2 (TAK1-binding protein 2) is an upstream adaptor protein in the IL-1 signaling pathway. Covalent modifications of TAB2 have not been well studied. In this study, we demonstrated that TAB2 could be modified by SUMO. ... Using Ubc9 (SUMO-conjugating enzyme) fusion and mutation analysis, we identified evolutionarily conserved lysine 329 as the major SUMOylation site of TAB2. PIAS3, a SUMO E3 ligase, preferentially interacted with and promoted its SUMOylation. Interestingly, block of SUMOylation by mutation of lysine 329 enhanced the activity of TAB2, as reflected by AP-1 luciferase reporter assays. Taken together, these results suggest that SUMOylation may serve as a novel mechanism for the regulation of TAB2.
Mesh Terms:
Adaptor Proteins, Signal Transducing, Amino Acid Sequence, Animals, HEK293 Cells, Humans, Interleukin-1, JNK Mitogen-Activated Protein Kinases, Lysine, Mice, Molecular Chaperones, Molecular Sequence Data, Protein Binding, Protein Inhibitors of Activated STAT, Signal Transduction, Sumoylation
Adaptor Proteins, Signal Transducing, Amino Acid Sequence, Animals, HEK293 Cells, Humans, Interleukin-1, JNK Mitogen-Activated Protein Kinases, Lysine, Mice, Molecular Chaperones, Molecular Sequence Data, Protein Binding, Protein Inhibitors of Activated STAT, Signal Transduction, Sumoylation
Mol. Cell. Biochem.
Date: Jan. 01, 2014
PubMed ID: 24096733
View in: Pubmed Google Scholar
Download Curated Data For This Publication
166700
Switch View:
- Interactions 3
- PTM Genes 1